We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current T1CH34 market cap is 2.11B. The company's latest EPS is USD 1.8119 and P/E is 39.26.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 294.15M | 301.32M | 276.94M | 272.6M | 303.43M |
| Operating Income | 80.09M | 93.38M | 53.57M | 36.09M | 65.25M |
| Net Income | 70.22M | 75.48M | 50.99M | 27.47M | 49.06M |
| Year End 30 June 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 714.01M | 738.69M | 931.03M | 1.11B | 1.14B |
| Operating Income | 146.72M | 157.42M | 237.3M | 296.59M | 297.8M |
| Net Income | 96.07M | 229.3M | 140.41M | 272.05M | 285.26M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 2.6B | 2.64B | 2.76B | 2.73B | 2.72B |
| Total Liabilities | 710.01M | 672.18M | 757.61M | 767.19M | 706.8M |
| Total Equity | 1.89B | 1.97B | 2B | 1.96B | 2.01B |
| Year End 30 June 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 1.88B | 2.03B | 2.26B | 2.29B | 2.64B |
| Total Liabilities | 718.82M | 646.4M | 691.72M | 593.79M | 672.18M |
| Total Equity | 1.17B | 1.38B | 1.57B | 1.7B | 1.97B |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 171M | 254.39M | 59.38M | 142.5M | 223.49M |
| Investing | -260.89M | -265.65M | -154.11M | -177.78M | -194.22M |
| Financing | 46.84M | 22.62M | 71.51M | -9.89M | -62.3M |
| Year End 30 June 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 181.62M | 205.22M | 352.16M | 325.27M | 254.39M |
| Investing | -336.8M | 27.1M | -243.52M | -96.85M | -265.65M |
| Financing | 134.38M | -183.8M | -62.55M | -242.85M | 22.62M |
| Market Cap | 2.11B |
| Price to Earnings Ratio | 39.26 |
| Price to Sales Ratio | 9.85 |
| Price to Cash Ratio | 62.03 |
| Price to Book Ratio | 5.7 |
| Dividend Yield | 0.31% |
| Shares Outstanding | 157.44M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 6 |
| 52 Week Change | 2.06% |
| 52 Week High | 14.38 |
| 52 Week Low | 5.01 |
| Spread (Intraday) | 10 (66.67%) |
| Company Name | Bio-Techne Corp |
| Address |
614 mckinley place n.e minneapolis, minnesota 55413 |
| Website | https://www.bio-techne.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
